Table 1.
Baseline characteristics of acetylcholinesterase inhibitor users, memantine users, users of both acetylcholinesterase inhibitor and memantine, and nonusers of both drugs among those diagnosed with Alzheimer’s disease in 2005 in the MEDALZ-2005 study
